New in Neurobiology
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
New in Neurobiology
Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session
Overview
This 1-hour, on-demand session from the 2022 ASAM State of the Art Course identifies new ways to treat, cure, and prevent addiction using advanced neuro-technologies.
Although addiction is widely understood to be a chronic brain disorder, the neurological basis and consequences of addiction remain poorly understood. The presentations in this 1-hour, on-demand session from the 2022 ASAM State of the Art Course identify new ways to treat, cure, and prevent addiction using advanced neuro-technologies. Following each presentation, presenters answer audience questions.
This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.
- Updates on the BRAIN Initiative
Emerging from formative years, the NIH BRAIN Initiative has matured into a vibrant enterprise spanning a diverse field of researchers from the biological, engineering, and clinical sciences from across the United States and around the world. The rising trajectory of the BRAIN Initiative as a major force in neuroscience discovery presents a timely opportunity to invest in new large-scale projects that offer the potential to transform the field. The BRAIN Initiative is rolling out three transformative projects that will (1) build an atlas of cell types in the human brain, (2) develop a microconnectivity map of an entire mammalian brain, and (3) provide tools for precision access to the identified cell types. Together, these will enable the development of novel interventions for human circuit disorders. - Brain Mechanisms of Relapse Prevention Medications for Opioid Use Disorder
Opioid use disorder (OUD) affects multiple neurocognitive domains. Non-invasive neuroimaging techniques, especially functional magnetic resonance imaging (fMRI), have shown great promise in elucidating the neural mechanisms of addiction in general and OUD in particular. The presentation will cover the key domains of OUD-related neurocognitive deficits such as abnormal incentive salience, poor executive control, aberrant emotional reactivity, impaired social cognition, and altered functional connectivity between brain regions. This will be followed by reviewing the fMRI results concerning effects of relapse prevention medications, including agonist and antagonist treatments, on the brain circuits affected by OUD. Lastly, the presentation will discuss the potential of advanced statistical and computational methodologies that may further our mechanistic understanding of OUD and its treatments.
These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:
- Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
- Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
- Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine
This conference addresses all 6 ACGME Competencies.
Learning Objectives
At the end of the course, learners should be able to:
- Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
- Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
- Develop practical applications for integrating new and emerging science into practice.
- Identify gaps in the field of addiction medicine that future research can address.
- Create a network of colleagues and resources to support the learner's practice or form future research collaborations.
Registration Rates
| ASAM Learner Type | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 10/1/2025
Instructions
- Click on the Contents tab to begin this activity.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Kathleen Page, MD (Moderator)
Associate Professor
Johns Hopkins University School of Medicine
Dr. Kathleen Page, MD, is an Associate Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Her work focuses on improving access and quality of care to underserved communities. She co-founded Centro SOL to meet the health needs of Latino migrants through research, education, advocacy, and clinical care. She is the Medical Director of The Johns Hopkins Access Partnership which provides care to uninsured patients with financial need. Her research focuses on migrant health, health disparities and implementation science.
No Relevant Financial Disclosures
John Ngai
PhD
John J. Ngai, Ph.D., is the Director of the NIH’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN®) Initiative. Dr. Ngai earned his bachelor’s degree in chemistry and biology from Pomona College, Claremont, California, and Ph.D. in biology from the California Institute of Technology (Caltech) in Pasadena. He was a postdoctoral researcher at Caltech and at the Columbia University College of Physicians and Surgeons before starting his faculty position at the University of California at Berkeley. During more than 25 years as a Berkeley faculty member, Dr. Ngai has trained 20 undergraduate students, 24 graduate students and 15 postdoctoral fellows in addition to teaching well over 1,000 students in the classroom.
His work has led to the publication of more than 70 scientific articles in some of the field’s most prestigious journals and 10 U.S. and international patents. Dr. Ngai has received many awards including from the Sloan Foundation, Pew Charitable Trusts, and McKnight Endowment Fund for Neuroscience. As a faculty member, Dr. Ngai has served as the director of Berkeley’s Neuroscience Graduate Program and Helen Wills Neuroscience Institute. He has also provided extensive service on NIH study sections, councils and steering groups, including as previous co-chair of the NIH BRAIN® Initiative Cell Census Consortium Steering Group. Dr. Ngai will oversee the long-term strategy and day-to-day operations of the NIH BRAIN Initiative as it takes on the challenges of the next five year plan.
No Relevant Financial Disclosures
Zhenhao Shi, PhD
Assistant Professor
University of Pennsylvania
Zhenhao Shi, PhD is an incoming Research Assistant Professor at the Department of Psychiatry at the University of Pennsylvania (UPenn). He received his BS in Psychology and PhD in Cognitive Neuroscience from Peking University in 2009 and 2014, respectively. He joined the UPenn Annenberg Public Policy Center as a postdoctoral fellow in 2014 and became a NIDA T32 fellow at the UPenn Department of Psychiatry in 2016. Dr. Shi’s research is focused on the neurocognitive mechanisms of addiction, with an emphasis on tobacco and opioid use disorders. Using behavioral, genetic and brain imaging methodologies, his work examined the neural, genetic and personality factors that contribute to the effectiveness of anti-smoking communications. He also investigated the predictive neural signatures of treatment outcomes in opioid use disorder and the neurobehavioral effects of opioid withdrawal and opioid antagonist treatment. Dr. Shi is currently the Principal Investigator of a NIDA K01 Award, which aims to establish multimodal neural prediction models for treatment outcomes in patients with opioid use disorder. He is also collaborating on a number of other scientific projects on alcohol use disorder and use of electronic cigarettes. Dr. Shi’s work has been recognized by a number of awards, including multiple scholarships, a Trainee Professional Development Award from the Society for Neuroscience, and a Travel Award for Early Career Investigators from the College on Problems of Drug Dependence.
No Relevant Financial Disclosures
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC) / Continuing Certification Program (CCP)
The ASAM State of the Art Course meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC
Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
Key:
Complete
Next
Failed
Available
Locked